Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Austrian patient standards on radiation and IVDs (in vitro diagnostics)

This article was originally published in Clinica

Executive Summary

The Austrian Standards Institute last week issued two standards aimed at improving the safety of patients and medical staff. The first concerns the hospital discharge of patients after radiotherapy. It sets out what level of radiation that can be safely emitted from a patient without harming other persons and is contained within part I of ONORM S 5275. A simple calculation method has been adopted in the standard, to determine the level of external emission of a patient. Exhalation of the patient, for radioactivity measurement purposes, is also taken into account.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel